default search action
"Developing Intermediary Medication Phenotypes via Metabolomics ..."
Matthew K. Breitenstein et al. (2015)
- Matthew K. Breitenstein, Richard M. Weinshilboum, Jyotishman Pathak, Liewei Wang:
Developing Intermediary Medication Phenotypes via Metabolomics Biotechnology Using an Electronic Health Record-Linked Biobank. AMIA 2015
manage site settings
To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.